Globus Medical, Inc. announced preliminary unaudited sales guidance for the fourth quarter and full year ending December 31, 2015. The company anticipates fourth quarter 2015 sales of approximately $142.6 million, growing 10.7% as reported or 11.5% in constant currency against fourth quarter 2014.

Full year 2015 estimated sales are expected to be approximately $544.7 million, growing 14.8% as reported or 16.0% in constant currency against the prior year, exceeding the company's previous guidance of $539 million.

The company established full year 2016 guidance of $583 million in sales and fully diluted earnings per share of $1.20. 2016 EPS guidance reflects an increase in net income in line with the expected sales growth, as well as a positive contribution from the recently-announced suspension of the Medical Device Tax. The full impact of the suspended Medical Device Tax is expected to be about $0.06 per share. 2016 guidance reflects approximately 7% growth in sales and 10% growth in EPS over the expected 2015 results.